Regulatory status of MSC therapy by country
Two different questions get confused constantly: "is this legal here?" and "does this work?". Regulators answer the first. This page maps the first question across major markets and keeps the second one separate.
How cell therapies are classified
Minimally manipulated tissue used for the same function it had in the donor is regulated lightly in most jurisdictions. Cells that are culture-expanded, or used for a different function, are generally regulated as medicinal products — drugs in the US, Advanced Therapy Medicinal Products (ATMPs) in the EU and UK. Almost all MSC therapy discussed by patients falls into the second category.
Is MSC therapy legal in my country?
Legality differs by jurisdiction. In the United States, most MSC products are unapproved biologics requiring an IND; in the EU they are advanced therapy medicinal products needing EMA or national authorisation; the UK regulates them through the MHRA; Türkiye permits use in licensed centres for defined indications. Check your own regulator before treatment or travel.
Key facts
- United States
- FDA: unapproved biologic for most uses
- European Union
- ATMP framework, EMA/national authorisation
- United Kingdom
- MHRA regulated
- Türkiye
- Permitted in licensed centres, defined indications
What we know
- Regulatory status is verifiable through each regulator's public registers.
- Treatment abroad does not change what is lawful at home.
What remains uncertain
- Rules are revised frequently; check the current position rather than a cached summary.
Medically reviewed questions
This summary is general medical information, not medical advice, and not a promise of benefit. Figures are quoted ranges, confirmed in writing after a medical review.
Medically reviewed by: Prof. Dr. Erdal Karaöz · Last updated: · Editorial and evidence policy
Market by market
| Market | Framework | Practical position |
|---|---|---|
| United States | FDA — cultured MSCs are biological drugs requiring an IND/BLA | No licensed MSC product for the indications on this site; access via trial — FDA cellular therapy products |
| European Union | EMA — ATMP regulation, with a national hospital-exemption route | No centrally authorised product for these indications — EMA ATMP overview |
| United Kingdom | MHRA — ATMP framework post-Brexit, Specials and hospital exemption | Trial access or exemption routes only — MHRA guidance |
| Türkiye | Ministry of Health licensing of production sites and treating centres | Lawful clinical use within the national framework; this is why patients travel |
| Japan | Conditional, time-limited approval pathway for regenerative products | Some products conditionally approved; conditional approval is not full approval |
| UAE | DoH/MoHAP licensing of facilities and protocols | Some regulated clinical use; requirements vary by emirate |
| India, Mexico, Panama, Ukraine | Varied national frameworks and enforcement | Availability differs sharply from oversight; verify the specific facility, not the country |
Approved cell therapies do exist
A handful of MSC or MSC-derived products have been licensed in specific jurisdictions and indications — for example in graft-versus-host disease. Darvadstrocel, approved in the EU for complex perianal fistulas in Crohn's disease, was subsequently withdrawn after a confirmatory trial did not meet its primary endpoint, which is a useful reminder that approval can be reversed by evidence.
What this means for your decision
- Legality tells you the treatment can be given lawfully at that site — nothing more.
- Check the facility's licence, not the country's reputation.
- If your indication has no controlled human evidence, a permissive jurisdiction does not fix that.
- Ask what would happen if you had a complication after returning home, and who would manage it.
Frequently asked questions
Is it illegal to travel abroad for stem cell therapy?
Travelling for lawful treatment in another country is generally not illegal for the patient. Your home insurer will usually not cover it, and your home physician may not have been consulted — both are worth resolving in advance.
Will my home doctor manage my follow-up?
Many will, if they receive a proper discharge summary and protocol. We write to your physician when you ask us to.
Read next
Have your records reviewed first
Whether any of this applies to you can only be decided after a physician reviews your medical records. The review is free and there is no obligation to travel.
Request a free medical review